Neuraxial analgesia-more commonly described as epidural pain relief-is the most effective means of managing pain during labor. 1 In 2015, nearly 3 out of 4 US women used epidural pain relief during labor. 2 Despite its popularity, flawed or misleading research has linked epidural pain relief to several unfavorable perinatal and postnatal outcomes, such as an increased risk of cesarean delivery or longterm back pain. 3 In response, anesthesia researchers have invested considerable time and effort to assuage these claims. 3 A recent population-based study of 147 895 live births in Kaiser Permanente Southern California hospitals reported that epidural pain relief is associated with a 37% increased risk of autism spectrum disorder in offspring. 4 However, residual confounding likely explains these findings, as a subsequent population-based study of 123 175 live births in Manitoba, Canada, did not confirm this association after accounting for a larger set of confounders. 5 Therefore, there is a need for more research that addresses selection and confounding bias to clarify the presence and extent of an association.Because assigning women to receive epidural pain relief or placebo in a randomized trial is unethical and immoral, high-quality longitudinal studies remain the only viable option for evaluating potential Open Access. This is an open access article distributed under the terms of the CC-BY License.